The global market leader for natural cosmetics, Weleda, has announced sales growth of more than eight per cent to 456 million euros for 2024. This is the highest turnover in its history, announced the company from Arlesheim near Basel. In the cosmetics business alone, turnover increased to 368 million euros. At the same time, the operating result more than doubled to 28 million euros. "Our positive development shows that our strategy of growth with responsibility is successful," said Tina Müller, CEO of Weleda AG. Weleda has expanded its international business and achieved double-digit sales growth in major markets such as Asia, the USA and Europe. New products such as Blue Gentian & Edelweiss facial care and the expansion of the rosemary hair care range were also sales drivers.

Leaner, faster - and always sustainable

Weleda introduced the independent Cosmetics and Pharma units at the beginning of 2024 and gave both areas more responsibility. At the same time, however, strong central functions were established and competences bundled. "This has made us faster, more efficient and more powerful," said Müller. The Swiss public limited company is now represented in more than 50 countries and employs around 2,200 people. Sustainability remains at the heart of the business model. Weleda remains committed to biodiversity, healthy soils and the circular economy, and its products remain certified natural products.

Perfumery and organic shop

At the same time, Weleda is focussing more strongly than before on innovations alongside traditional products. The multi-generational line "minLen" with Princess Madeleine of Sweden is just the first of a whole series of new cosmetic products that Weleda will be launching this year. With the new "Cell Longevity" facial care, the company is also positioning itself more strongly in the premium market and wants to make its presence felt in perfumeries with both product lines, emphasised Müller. At the same time, Weleda has modernised its image and is now increasingly appealing to younger target groups.

Source: Weleda